Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use
Open Access
- 14 November 2022
- Vol. 41 (11) , 1819-1825
Abstract
No abstract availableKeywords
Funding Information
- Merck Sharp and Dohme United Kingdom
This publication has 19 references indexed in Scilit:
- Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008–2011Vaccine, 2016
- Unmasking in an observational vaccine safety study: Using type 2 diabetes mellitus as an exampleVaccine, 2015
- An Overview of Quadrivalent Human Papillomavirus Vaccine SafetyThe Pediatric Infectious Disease Journal, 2015
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in WomenNew England Journal of Medicine, 2015
- Sexually Transmitted Infections Among US Women and MenSexually Transmitted Diseases, 2013
- Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to FemalesArchives of Pediatrics & Adolescent Medicine, 2012
- An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young womenVaccine, 2012
- Flagging clinical adverse experiences: reducing false discoveries without materially compromising power for detecting true signalsStatistics in Medicine, 2012
- Four different study designs to evaluate vaccine safety were equally validated with contrasting limitationsJournal of Clinical Epidemiology, 2006
- Syncope After ImmunizationArchives of Pediatrics & Adolescent Medicine, 1997